ARTICLE | Company News
Discovery Laboratories pulmonary news
March 23, 2015 7:00 AM UTC
Discovery Laboratories disclosed in its 2014 financial results that it will restructure to focus on development of Aerosurf aerosolized KL4 surfactant for respiratory diseases, beginning with respiratory distress syndrome (RDS) in premature infants. Discovery Labs expects to complete an ongoing Phase IIb trial of Aerosurf in the indication in 2Q16. ...